MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE
Clinical trials for MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a spinal injection slow Alzheimer's? new trial underway
Disease control OngoingThis Phase 2 study tests an experimental drug called BIIB080 in people with mild cognitive impairment or mild dementia due to Alzheimer's disease. The drug is injected into the fluid around the spinal cord every 12 or 24 weeks. Researchers want to see if it can slow the worsening…
Matched conditions: MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Biogen • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a new pill break up Alzheimer's brain clumps?
Disease control OngoingThis study tests a new drug called PRI-002 in 304 people with mild memory problems or early Alzheimer's. The drug aims to break apart harmful protein clumps in the brain that are linked to Alzheimer's. Researchers want to see if it is safe and can slow down memory and thinking de…
Matched conditions: MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: PRInnovation GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could an HIV drug protect the aging brain?
Disease control OngoingThis pilot study tests whether lamivudine, an antiviral drug used for HIV, can lower levels of brain-damage-related proteins in the blood of people with mild cognitive impairment (MCI) who also have early signs of Alzheimer's disease. Twenty-three participants will take lamivudin…
Matched conditions: MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a diabetes drug help detect Alzheimer's early?
Diagnosis OngoingThis early-phase study tests whether a single injection of pramlintide, a diabetes drug, can temporarily increase levels of Alzheimer's-related proteins in the blood, potentially revealing early signs of the disease. Researchers will measure changes in beta-amyloid and tau protei…
Matched conditions: MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE
Phase: EARLY_PHASE1 • Sponsor: Boston University • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC